{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:27Z","timestamp":1787022807031,"version":"build-2736575974"},"reference-count":38,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Incidental uptake within or adjacent to the thyroid gland is occasionally observed on somatostatin receptor-targeted PET imaging in patients with neuroendocrine neoplasms (NENs). The reported prevalence and clinical relevance of such findings are not well established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We reviewed PET scan reports for all patients undergoing [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga-DOTA-TOC PET\/CT or [\n                      <jats:sup>64<\/jats:sup>\n                      Cu]Cu-DOTA-TATE PET\/CT in our department from 2018 to 2022. Scans reporting incidental uptake within or adjacent to the thyroid gland were reviewed post hoc to extract semi-quantitative scores of tracer uptake for the incidental lesions. We further extracted data from electronic patient charts, including cytology and histology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3692 PET scans were performed on 1808 unique patients. Incidental abnormal thyroid uptake was reported in 42 of the 1808 patients, with thyroid malignancy identified in five of these 42 patients. Two patients had medullary thyroid cancers, two had neuroendocrine tumor metastases, and one had a renal clear cell carcinoma metastasis. Focal uptake in close relation to the thyroid gland, suggestive of parathyroid adenoma, was reported in another 13 of the 1808 patients, with biochemical hyperparathyroidism found in six of these 13 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients undergoing somatostatin receptor-targeted PET scans for evaluation of NENs, the prevalence of reported abnormal uptake within or adjacent to the thyroid gland was low. However, the rates of thyroid malignancy and parathyroid adenomas were substantial. Prospective studies are needed to determine the optimal diagnostic and therapeutic strategies for these incidental findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0419","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:23:48Z","timestamp":1732177428000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["Abnormal uptake related to the thyroid gland on somatostatin receptor-targeted PET imaging: reported prevalence and rate of thyroid malignancy and parathyroid adenomas"],"prefix":"10.1530","volume":"13","author":[{"given":"Sannia Mia Svenningsen","family":"Sj\u00f6stedt","sequence":"first","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer Holst","family":"Hahn","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark"},{"name":"Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se Krogh","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Sandor","family":"Oturai","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-6225","authenticated-orcid":true,"given":"Per Karkov","family":"Cramon","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Nuclear Medicine","first-page":"451","article-title":"Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"Johnbeck","year":"2017","unstructured":"Johnbeck CBKnigge ULoft ABerthelsen AKMortensen JOturai PLanger SWElema DR & Kjaer A. Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors. Journal of Nuclear Medicine 2017 58 451\u2013457. (https:\/\/doi.org\/10.2967\/JNUMED.116.180430)"},{"key":"bib2","series-title":"American Journal of Roentgenology","first-page":"267","article-title":"Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT","volume":"211","author":"Sanli","year":"2018","unstructured":"Sanli YGarg IKandathil AKendi TBaladron Zanetti MJBKuyumcu S & Subramaniam RM. Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT. American Journal of Roentgenology 2018 211 267\u2013277. (https:\/\/doi.org\/10.2214\/AJR.18.19881)"},{"key":"bib3","series-title":"Nuclear Medicine Review. Central and Eastern Europe","first-page":"111","article-title":"Neuroendocrine neoplasms and somatostatin receptor subtypes expression","volume":"19","author":"Hankus","year":"2016","unstructured":"Hankus J & Tomaszewska R. Neuroendocrine neoplasms and somatostatin receptor subtypes expression. Nuclear Medicine Review. Central and Eastern Europe 2016 19 111\u2013117. (https:\/\/doi.org\/10.5603\/NMR.2016.0022)"},{"key":"bib4","series-title":"Visceral Medicine","first-page":"324","article-title":"Neuroendocrine neoplasms: dichotomy, origin and classifications","volume":"33","author":"Kl\u00f6ppel","year":"2017","unstructured":"Kl\u00f6ppel G. Neuroendocrine neoplasms: dichotomy, origin and classifications. Visceral Medicine 2017 33 324\u2013330. (https:\/\/doi.org\/10.1159\/000481390)"},{"key":"bib5","series-title":"Nuclear Medicine Communications","first-page":"510","article-title":"Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity","volume":"42","author":"Kohlenberg","year":"2021","unstructured":"Kohlenberg JDPanda AJohnson GB & Castro MR. Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity. Nuclear Medicine Communications 2021 42 510\u2013516. (https:\/\/doi.org\/10.1097\/MNM.0000000000001356)"},{"key":"bib6","series-title":"Cancer Imaging","first-page":"44","article-title":"Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET\/CT: a systematic review of the literature","volume":"22","author":"Bentestuen","year":"2022","unstructured":"Bentestuen MGossili FAlmasi CE & Zacho HD. Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET\/CT: a systematic review of the literature. Cancer Imaging 2022 22 44. (https:\/\/doi.org\/10.1186\/S40644-022-00484-0)"},{"key":"bib7","series-title":"American Journal of Surgery","first-page":"670","article-title":"68Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: a systematic review","volume":"224","author":"Pajak","year":"2022","unstructured":"Pajak CCadili LNabata K & Wiseman SM. 68Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: a systematic review. American Journal of Surgery 2022 224 670\u2013675. (https:\/\/doi.org\/10.1016\/J.AMJSURG.2022.03.046)"},{"key":"bib8","series-title":"Annals of Nuclear Medicine","first-page":"663","article-title":"Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer","volume":"34","author":"Tuncel","year":"2020","unstructured":"Tuncel MK\u0131l\u0131\u00e7kap S & S\u00fcsl\u00fc N. Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer. Annals of Nuclear Medicine 2020 34 663\u2013674. (https:\/\/doi.org\/10.1007\/S12149-020-01494-3)"},{"key":"bib9","series-title":"Endocrine Reviews","first-page":"133","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","unstructured":"Brandi MLAgarwal SKPerrier NDLines KEValk GD & Thakker RV. Multiple endocrine neoplasia type 1: latest insights. Endocrine Reviews 2021 42 133\u2013170. (https:\/\/doi.org\/10.1210\/ENDREV\/BNAA031)"},{"issue":"Supplement 1","key":"bib10","series-title":"Revista Espanola de Medicina Nuclear e Imagen Molecular","first-page":"S66","article-title":"[68Ga] Ga-DOTA-TOC PET\/CT uptake by parathyroid adenoma in the context of multiple endocrine neoplasia type 1 (MEN1)","volume":"41","author":"Carrero-V\u00e1squez","year":"2022","unstructured":"Carrero-V\u00e1squez V & Prado-Wohlwend S. [68Ga] Ga-DOTA-TOC PET\/CT uptake by parathyroid adenoma in the context of multiple endocrine neoplasia type 1 (MEN1). Revista Espanola de Medicina Nuclear e Imagen Molecular 2022 41(Supplement 1) S66\u2013S68. (https:\/\/doi.org\/10.1016\/J.REMNIE.2022.04.004)"},{"key":"bib11","series-title":"Lancet","first-page":"1531","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","unstructured":"Chen DWLang BHHMcLeod DSANewbold K & Haymart MR. Thyroid cancer. Lancet 2023 401 1531\u20131544. (https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X)"},{"key":"bib12","series-title":"Nuclear Medicine and Molecular Imaging","first-page":"31","article-title":"Management impact of 68Ga-DOTATATE PET\/CT in neuroendocrine tumors","volume":"55","author":"Anderson","year":"2021","unstructured":"Anderson RCVelez EMDesai B & Jadvar H. Management impact of 68Ga-DOTATATE PET\/CT in neuroendocrine tumors. Nuclear Medicine and Molecular Imaging 2021 55 31\u201337. (https:\/\/doi.org\/10.1007\/S13139-020-00677-0)"},{"key":"bib13","series-title":"Nuclear Medicine and Molecular Imaging","first-page":"238","article-title":"Incidental detection of parathyroid adenoma on somatostatin receptor PET\/CT and incremental role of 18F-Fluorocholine PET\/CT in MEN1 syndrome","volume":"52","author":"Arora","year":"2018","unstructured":"Arora SDamle NAPassah AYadav MPBallal SAggarwal VGupta YKumar PTripathi M & Bal C. Incidental detection of parathyroid adenoma on somatostatin receptor PET\/CT and incremental role of 18F-Fluorocholine PET\/CT in MEN1 syndrome. Nuclear Medicine and Molecular Imaging 2018 52 238\u2013242. (https:\/\/doi.org\/10.1007\/S13139-018-0520-2)"},{"key":"bib14","series-title":"Endocrine Connections","first-page":"1213","article-title":"Somatostatin receptor expression in parathyroid neoplasms","volume":"8","author":"Storvall","unstructured":"Storvall SLeijon HRyh\u00e4nen ELouhimo JHaglund CSchalin-J\u00e4ntti C & Arola J. Somatostatin receptor expression in parathyroid neoplasms. Endocrine Connections 8 1213\u20131223. (https:\/\/doi.org\/10.1530\/EC-19-0260)"},{"key":"bib15","series-title":"Indian Journal of Nuclear Medicine","first-page":"447","article-title":"Ectopic parathyroid adenoma mimicking as a neuroendocrine tumor on Ga68-DOTANOC positron emission tomography\/computed tomography imaging","volume":"36","author":"Subramanian","year":"2021","unstructured":"Subramanian KKrishnaraju VSKumar RBhadada S & Mittal BR. Ectopic parathyroid adenoma mimicking as a neuroendocrine tumor on Ga68-DOTANOC positron emission tomography\/computed tomography imaging. Indian Journal of Nuclear Medicine 2021 36 447\u2013448. (https:\/\/doi.org\/10.4103\/IJNM.IJNM_59_21)"},{"key":"bib16","series-title":"Trends in Pharmacological Sciences","first-page":"86","article-title":"Classification and nomenclature of somatostatin receptors","volume":"16","author":"Hoyer","year":"1995","unstructured":"Hoyer DBell GIBerelowitz MEpelbaum JFeniuk WHumphrey PPAO\u2019Carroll AMPatel YCSchonbrunn ATaylor JE, et al. Classification and nomenclature of somatostatin receptors. Trends in Pharmacological Sciences 1995 16 86\u201388. (https:\/\/doi.org\/10.1016\/S0165-6147(00)88988-9)"},{"issue":"Supplement 1","key":"bib17","series-title":"Neuroendocrinology","first-page":"51","article-title":"Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment","volume":"80","author":"Reubi","year":"2004","unstructured":"Reubi JC. Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 2004 80(Supplement 1) 51\u201356. (https:\/\/doi.org\/10.1159\/000080742)"},{"key":"bib18","series-title":"European Journal of Nuclear Medicine","first-page":"836","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","unstructured":"Reubi JCWaser BSchaer JC & Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. European Journal of Nuclear Medicine 2001 28 836\u2013846. (https:\/\/doi.org\/10.1007\/S002590100541)"},{"issue":"Supplement 2","key":"bib19","series-title":"Italian Journal of Gastroenterology and Hepatology","first-page":"S219","article-title":"Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide","volume":"31","author":"Krenning","year":"1999","unstructured":"Krenning EPValkema RKooij PPBreeman WABakker WHdeHerder WWvanEijck CHKwekkeboom DJdeJong M & Pauwels S. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. Italian Journal of Gastroenterology and Hepatology 1999 31(Supplement 2) S219\u2013S223."},{"key":"bib20","series-title":"EJNMMI Physics","first-page":"40","article-title":"Method to determine the statistical technical variability of SUV metrics","volume":"9","author":"De Luca","year":"2022","unstructured":"De Luca GMR & Habraken JBA. Method to determine the statistical technical variability of SUV metrics. EJNMMI Physics 2022 9 40. (https:\/\/doi.org\/10.1186\/S40658-022-00470-2)"},{"key":"bib21","series-title":"Diagnostics","article-title":"Long-term follow-up of thyroid incidentalomas visualized with 18F-Fluorodeoxyglucose positron emission tomography-impact of thyroid scintigraphy in the diagnostic work-up","volume":"11","author":"Korsholm","year":"2021","unstructured":"Korsholm KReichkendler MAlslev LRasmussen \u00c5K & Oturai P. Long-term follow-up of thyroid incidentalomas visualized with 18F-Fluorodeoxyglucose positron emission tomography-impact of thyroid scintigraphy in the diagnostic work-up. Diagnostics 2021 11. (https:\/\/doi.org\/10.3390\/DIAGNOSTICS11030557)"},{"key":"bib22","series-title":"Clinical Cancer Research","first-page":"1399","article-title":"177Lu-DOTA-EB-TATE, a radiolabeled analogue of somatostatin receptor type 2, for the imaging and treatment of thyroid cancer","volume":"27","author":"Thakur","year":"2021","unstructured":"Thakur SDaley BMillo CCochran CJacobson OLu HWang ZKiesewetter DChen XVasko V, et al. 177Lu-DOTA-EB-TATE, a radiolabeled analogue of somatostatin receptor type 2, for the imaging and treatment of thyroid cancer. Clinical Cancer Research 2021 27 1399\u20131409. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3453)"},{"key":"bib23","series-title":"Journal of Nuclear Medicine","first-page":"204","article-title":"SNMMI procedure standard\/EANM practice guideline for sstr PET: imaging neuroendocrine tumors","volume":"64","author":"Hope","year":"2023","unstructured":"Hope TAAllen-Auerbach MBodei LCalais JDahlbom MDunnwald LKGraham MMJacene HAHeath CLMittra ES, et al. SNMMI procedure standard\/EANM practice guideline for sstr PET: imaging neuroendocrine tumors. Journal of Nuclear Medicine 2023 64 204\u2013210. (https:\/\/doi.org\/10.2967\/JNUMED.122.264860)"},{"key":"bib24","series-title":"Annals of Nuclear Medicine","first-page":"900","article-title":"Evaluation of F-18 DOPA PET\/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET\/CT","volume":"35","author":"Asa","year":"2021","unstructured":"Asa SSonmezoglu KUslu-Besli LSahin OEKarayel EPehlivanoglu HSager SKabasakal LOcak M & Sayman HB. Evaluation of F-18 DOPA PET\/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET\/CT. Annals of Nuclear Medicine 2021 35 900\u2013915. (https:\/\/doi.org\/10.1007\/S12149-021-01627-2)"},{"key":"bib25","series-title":"Cancers","article-title":"Molecular imaging and theragnostics of thyroid cancers","volume":"14","author":"Giovanella","year":"2022","unstructured":"Giovanella LDeandreis DVrachims ACampenni A & Ovcaricek PP. Molecular imaging and theragnostics of thyroid cancers. Cancers 2022 14. (https:\/\/doi.org\/10.3390\/CANCERS14051272)"},{"key":"bib26","series-title":"Seminars in Cancer Biology","first-page":"163","article-title":"Multiple endocrine neoplasia type 2: a review","volume":"79","author":"Mathiesen","year":"2022","unstructured":"Mathiesen JSEffraimidis GRossing MRasmussen \u00c5KHoejberg LBastholt LGodballe COturai P & Feldt-Rasmussen U. Multiple endocrine neoplasia type 2: a review. Seminars in Cancer Biology 2022 79 163\u2013179. (https:\/\/doi.org\/10.1016\/J.SEMCANCER.2021.03.035)"},{"key":"bib27","series-title":"Current Oncology","first-page":"338","article-title":"Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines","volume":"26","author":"Thomas","year":"2019","unstructured":"Thomas CMAsa SLEzzat SSawka AM & Goldstein D. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Current Oncology 2019 26 338\u2013344. (https:\/\/doi.org\/10.3747\/CO.26.5539)"},{"key":"bib28","series-title":"Clinical Epidemiology","first-page":"1479","article-title":"Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901\u20132014: a nationwide study","volume":"10","author":"Mathiesen","year":"2018","unstructured":"Mathiesen JSKroustrup JPVestergaard PStochholm KPoulsen PLRasmussen \u00c5KFeldt-Rasmussen USchytte SPedersen HBHahn CH, et al. Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901\u20132014: a nationwide study. Clinical Epidemiology 2018 10 1479\u20131487. (https:\/\/doi.org\/10.2147\/CLEP.S174606)"},{"key":"bib29","series-title":"Clinical Nuclear Medicine","first-page":"583","article-title":"Metastatic renal cell carcinoma in the thyroid gland and pancreas showing uptake on 68Ga DOTATATE PET\/CT scan","volume":"41","author":"Kanthan","year":"2016","unstructured":"Kanthan GLSchembri GPSamra JRoach P & Hsiao E. Metastatic renal cell carcinoma in the thyroid gland and pancreas showing uptake on 68Ga DOTATATE PET\/CT scan. Clinical Nuclear Medicine 2016 41 583\u2013584. (https:\/\/doi.org\/10.1097\/RLU.0000000000001227)"},{"key":"bib30","series-title":"World Journal of Nuclear Medicine","first-page":"195","article-title":"Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: three case reports and a review of the literature","volume":"17","author":"Nadebaum","year":"2018","unstructured":"Nadebaum DPLee STNikfarjam M & Scott AM. Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: three case reports and a review of the literature. World Journal of Nuclear Medicine 2018 17 195\u2013197. (https:\/\/doi.org\/10.4103\/wjnm.WJNM_38_17)"},{"key":"bib31","series-title":"Surgery","first-page":"168","article-title":"Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian","year":"2020","unstructured":"Pandian TKLubitz CCBird SHKuo LE & Stephen AE. Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis. Surgery 2020 167 168\u2013172. (https:\/\/doi.org\/10.1016\/j.surg.2019.06.043)"},{"key":"bib32","series-title":"Lancet","first-page":"145","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet 2009 374 145\u2013158. (https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9)"},{"key":"bib33","series-title":"JAMA","first-page":"1186","article-title":"Diagnosis and management of primary hyperparathyroidism","volume":"323","author":"Zhu","year":"2020","unstructured":"Zhu CYSturgeon C & Yeh MW. Diagnosis and management of primary hyperparathyroidism. JAMA 2020 323 1186\u20131187. (https:\/\/doi.org\/10.1001\/JAMA.2020.0538)"},{"key":"bib34","series-title":"Histopathology","first-page":"117","article-title":"Heritable forms of primary hyperparathyroidism: a current perspective","volume":"72","author":"DeLellis","year":"2018","unstructured":"DeLellis RA & Mangray S. Heritable forms of primary hyperparathyroidism: a current perspective. Histopathology 2018 72 117\u2013132. (https:\/\/doi.org\/10.1111\/HIS.13306)"},{"key":"bib35","series-title":"Pathology","first-page":"316","article-title":"Precursor lesions of endocrine system neoplasms","volume":"45","author":"Mete","year":"2013","unstructured":"Mete O & Asa SL. Precursor lesions of endocrine system neoplasms. Pathology 2013 45 316\u2013330. (https:\/\/doi.org\/10.1097\/PAT.0b013e32835f45c5)"},{"key":"bib36","series-title":"World Journal of Nuclear Medicine","first-page":"99","article-title":"Comparison of 68Ga-DOTA-NaI3-Octreotide\/tyr3-octreotate positron emission tomography\/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome","volume":"19","author":"Patil","year":"2020","unstructured":"Patil VAGoroshi MRShah HMalhotra GHira PSarathi VLele VRJadhav SLila ABandgar TR, et al. Comparison of 68Ga-DOTA-NaI3-Octreotide\/tyr3-octreotate positron emission tomography\/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome. World Journal of Nuclear Medicine 2020 19 99\u2013105. (https:\/\/doi.org\/10.4103\/wjnm.WJNM_24_19)"},{"key":"bib37","series-title":"World Journal of Surgery","first-page":"1993","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","unstructured":"Schreinemakers JMJPieterman CRCScholten AVriens MRValk GD & Borel Rinkes IHM. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World Journal of Surgery 2011 35 1993\u20132005. (https:\/\/doi.org\/10.1007\/S00268-011-1068-9)"},{"key":"bib38","series-title":"American Journal of Roentgenology","first-page":"218","article-title":"Opportunistic CT assessment of parathyroid glands: utility of radiologist-recommended biochemical evaluation for diagnosing primary hyperparathyroidism","volume":"221","author":"Bunch","year":"2023","unstructured":"Bunch PMAribindi SGorris MA & Randle RW. Opportunistic CT assessment of parathyroid glands: utility of radiologist-recommended biochemical evaluation for diagnosing primary hyperparathyroidism. American Journal of Roentgenology 2023 221 218\u2013227. (https:\/\/doi.org\/10.2214\/AJR.23.29049)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/13\/12\/EC-24-0419.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/12\/EC-24-0419.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/12\/EC-24-0419.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:29Z","timestamp":1784555249000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":38,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0419","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]}}}